Nextstellis

Chemical Namedrospirenone and estetrol
Dosage FormTablet (oral; 24 pink active tablets each containing drospirenone 3 mg and estetrol 14.2 mg, and 4 white inert tablets)
Drug ClassHormones
SystemFemale reproductive
CompanyMayne Pharma
Approval Year2021

Indication

  • Indicated for use by females of reproductive potential to prevent pregnancy.
Last updated on 4/30/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Nextstellis (drospirenone and estetrol) Prescribing Information2021Mayne Pharma, Greenville, NC